icIL-1ra fragments (University of Tennessee)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameicIL-1ra fragments (University of Tennessee)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterleukin-1 receptor antagonistsMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinaseInterleukin-1 receptor
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Tennessee
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Tennessee Research Foundation Office of Technology TransferThe University Of Tennessee
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A